Daniel Raynor Net Worth & Insider Trades
Daniel Raynor - Director, Ani Pharmaceuticals Inc
What is Daniel Raynor's Net Worth?
The current estimated net worth of Ani Pharmaceuticals Inc's Director, Daniel Raynor, is estimated to be about $28.87M . Daniel Raynor owns about 289,003 units of Ani Pharmaceuticals Inc common stock. In the last 5 years at Ani Pharmaceuticals Inc, Daniel Raynor has sold an estimated value of $15.91M worth.
What is Daniel Raynor's Past Insider Trading?
Daniel Raynor's largest sale order was 200,000 units , worth over $12.6M on March 16, 2015. In total, Daniel Raynor has made about 10 transactions over 5 years of their time at Ani Pharmaceuticals Inc. Daniel Raynor usually trades in March, with the busiest year in 2014. The most recent transaction was a sale order of 7,215 units , worth over $439.05K on March 19, 2018.
Daniel Raynor
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What are Ani Pharmaceuticals Inc's Past Insider Trades?
Ani Pharmaceuticals Inc's most recent insider trade came on December 2, 2022 by Meridian Venture Partners Ii Lp, Meridian Venture Partners Ii GP Lp, Meridian Venture Partners Ii Co and Robert E. Brown Jr. who sold 200,000 units worth $7.7M . In the last 9 years, insiders at Ani Pharmaceuticals Inc have sold an estimated value of $118.51M and bought an estimated value of $6.24M worth of shares. Insider trading is most common in April, with the busiest year in 2013. The most active traders at the company are Arthur Przybyl, President and CEO, James G Marken, SVP OPS & PROD DEV, and Charlotte C Arnold, Vice President and CFO .
ANI PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||